Pharming Group N.V. Tax Expense Income At Applicable Tax Rate
Pharming Group N.V. (PHAR) reported Tax Expense Income At Applicable Tax Rate of $3.31 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:TaxExpenseIncomeAtApplicableTaxRate · last filed 2026-04-02
EUR
| Period end | Tax Expense Income At Applicable Tax Rate 12 month |
|---|---|
| 2020-12-31 | 9.65M EUR 20-F · filed 2021-04-07 |
| 2019-12-31 | 11.67M EUR 20-F · filed 2021-04-07 |
| 2018-12-31 | 214.00K EUR 20-F · filed 2021-04-07 |
USD
| Period end | Tax Expense Income At Applicable Tax Rate 12 month |
|---|---|
| 2025-12-31 | $3.31M 20-F · filed 2026-04-02 |
| 2024-12-31 | -$2.19M 20-F · filed 2026-04-02 |
| 2023-12-31 | -$3.10M 20-F · filed 2026-04-02 |
| 2022-12-31 | $3.87M 20-F · filed 2025-04-03 |
| 2021-12-31 | $5.77M 20-F · filed 2024-04-04 |
| 2020-12-31 | $11.02M 20-F · filed 2023-04-05 |
| 2019-12-31 | $13.08M 20-F · filed 2022-04-06 |